Teaching information for CMA

If you are interested in using CMA to teach a class in meta-analysis, please submit your e-mail here for more information.

Valid e-mail is required.

Please provide the university / organization, the approximate class size, and the course duration below.

Details are required.

"Our group has recently begun to conduct meta‐analyses within our area of research, i.e. psychooncology and health psychology, and we have found CMA extremely useful. CMA distinguishes itself from other available meta‐analysis software by the various options to explore and adjust for possible publication bias, as well as by providing several options to explore possible moderators, not only categorical but also continuous. We encourage our PhD students to conduct quantitative systematic reviews as a part of their dissertation whenever possible. The clear menu‐driven approach of CMA makes it easy to use for beginners, so that they can focus their energy on the analytical aspects of metaanalysis, rather than on the technical issues of using the software."

Bobby (Robert) Zachariae - Professor, dr.med., Psycho‐oncology Research Unit, Aarhus University Hospital, Denmark


"The program in Comparative Effectiveness and Outcomes Research at Duke University conducts multiple systematic reviews and meta‐analyses each year for professional organizations as well as under both federal and industry sponsored research initiatives. While we use various programs tailored for specific individual projects including those developed in‐house, we have found Comprehensive Meta‐Analysis (CMA) to be a very facile, adaptable and yet comprehensive package meeting the needs for much of our research and generating publication‐quality graphics. My confidence in the analytic algorithms is buoyed by my knowledge of several of the developers of CMA and based on extensive comparison of results with other algorithms including our own. CMA is also an exceptional educational tool and universally embraced by trainees and young investigators initiating careers in evidence‐based medicine and statistical analysis."

Gary H Lyman, MD, MPH, FRCP (Edin) - Professor of Medicine and Director, Comparative Effectiveness and Outcomes Research, Duke University School of Medicine, and the Duke Comprehensive Cancer Center, Senior Fellow, Duke Center for Clinical Health Policy Research, Durham, NC